Cue Biopharma, Inc. (CUE)
23.18
-0.80
(-3.34%)
USD |
NASDAQ |
Aug 24, 16:00
23.16
-0.02
(-0.09%)
After-Hours: 20:00
Cue Biopharma Total Assets (Quarterly) : 30.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.71M |
| March 31, 2026 | 30.88M |
| December 31, 2025 | 43.14M |
| September 30, 2025 | 31.64M |
| June 30, 2025 | 40.71M |
| March 31, 2025 | 22.25M |
| December 31, 2024 | 32.19M |
| September 30, 2024 | 44.81M |
| June 30, 2024 | 42.33M |
| March 31, 2024 | 53.95M |
| December 31, 2023 | 61.53M |
| September 30, 2023 | 68.89M |
| June 30, 2023 | 73.16M |
| March 31, 2023 | 81.68M |
| December 31, 2022 | 91.28M |
| September 30, 2022 | 76.30M |
| June 30, 2022 | 84.75M |
| March 31, 2022 | 90.70M |
| Date | Value |
|---|---|
| December 31, 2021 | 83.40M |
| September 30, 2021 | 78.88M |
| June 30, 2021 | 89.67M |
| March 31, 2021 | 88.72M |
| December 31, 2020 | 99.53M |
| September 30, 2020 | 106.62M |
| June 30, 2020 | 101.35M |
| March 31, 2020 | 60.65M |
| December 31, 2019 | 71.60M |
| September 30, 2019 | 45.21M |
| June 30, 2019 | 41.76M |
| March 31, 2019 | 45.19M |
| December 31, 2018 | 45.36M |
| September 30, 2018 | 44.58M |
| June 30, 2018 | 53.11M |
| March 31, 2018 | 59.33M |
| December 31, 2017 | 66.95M |
| September 30, 2017 | 6.295M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Fortress Biotech, Inc. | 316.72M |
| Equillium, Inc. | 58.67M |
| Legend Biotech Corp. | 1.751B |
| Nurix Therapeutics, Inc. | 535.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.40M |
| Shareholders Equity (Quarterly) | 2.31M |
| Debt to Equity Ratio | 3.813 |
| Current Ratio | 1.255 |
| Net Debt Paydown Yield | -0.20% |